These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 13152939)

  • 1. [Analysis of fatality in hypertrophy of the prostate].
    VOROBTSOV VI
    Khirurgiia (Mosk); 1954 Feb; 2():60-4. PubMed ID: 13152939
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
    Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
    Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
    Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Hinerman-Mulroy A; Galbreath RW
    Brachytherapy; 2003; 2(3):181-8. PubMed ID: 15062141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flutamide suppressed prostate hypertrophy in rats and mice.
    Zhang YY; Li PF; Chen BL; Li D
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):537-40. PubMed ID: 10678149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
    Lai JS; Xia Q; Zhang XB; Zhao GP; Xu SL; Zheng DS
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Giant hypertrophy of the prostate: 2,410 grams of weight and 24 cm in diameter].
    Medina Pérez M; Valero Puerta J; Valpuesta Fernández I; Sánchez González M
    Arch Esp Urol; 1997 Sep; 50(7):795-7. PubMed ID: 9412386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of benign prostate hypertrophy in Calabar.
    Umezurike BI; Ekanem TB; Eluwa MA; Etta KK; Udo-Affah GA; Aligwekwe AU
    Niger Postgrad Med J; 2006 Sep; 13(3):236-9. PubMed ID: 17278305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of levorin on the chromatin of the prostate of dogs in its hypertrophy].
    Kravchenko LS; Oksman AIa; Konstantinova IM; Tereshin IM
    Antibiotiki; 1979 Mar; 24(3):212-7. PubMed ID: 87145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
    Yoshida H; Haraguchi C; Ogawa Y; Kawai N; Ohyama M; Higaki Y; Saitoh T; Imamura K
    Hinyokika Kiyo; 1983 Nov; 29(11):1419-26. PubMed ID: 6203377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume].
    Qiu MX; Wang D; Wu HM; Xiong GB; Chen ZX
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1852-3. PubMed ID: 17922999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein expression in human prostate gland.
    Bataineh ZM; Nusier MK
    Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign hypertrophy of the prostate.
    Mogere RM; Baraza R
    East Afr Med J; 2007 Dec; 84(12):553-5. PubMed ID: 18402305
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of hypertrophy of the prostate of rats with 4-nitro-3-trifluoromethylisobutyranilide (Sch 13521).
    Syrkin AB; Smirnova IO; Lazarev NI
    Arzneimittelforschung; 1977 Jul; 27(7):1467-9. PubMed ID: 71154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.
    Van Cangh PJ; De Nayer P; Sauvage P; Tombal B; Elsen M; Lorge F; Opsomer R; Wese FX
    Prostate Suppl; 1996; 7():30-4. PubMed ID: 8950361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Millin's operation in prostate hypertrophy].
    SCHROEDER E
    Nord Med; 1954 Oct; 52(42):1459-60. PubMed ID: 13214545
    [No Abstract]   [Full Text] [Related]  

  • 19. [Two-stage transvesical adenomectomy in adenomatous hypertrophy of the prostate].
    BLIZNIUK VM
    Urol Mosc; 1956; 21(3):18-21. PubMed ID: 13401628
    [No Abstract]   [Full Text] [Related]  

  • 20. Transurethral resection in benign hypertrophy of the prostate.
    CREEVY CD
    Geriatrics; 1952; 7(2):130-6. PubMed ID: 14906752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.